Georgios Skretas, PhD
Bachelor’s degree from the School of Chemical Engineering, National Technical University of Athens (Greece); PhD in Chemical and Biological Engineering from Princeton University (USA)
Biomolecular engineering, synthetic biology, chemical biology, enzyme discovery and engineering, discovery and development of next-generation antibiotics
New member of the ICTER ISC for the term 2024-2028, Dr. Georgios Skretas worked as a post-doctoral research associate at the Institute of Cell and Molecular Biology of the University of Texas at Austin (USA) (2006-2009). In 2010, he received a Marie Curie International Reintegration Fellowship to return to Greece and establish his independent research group in his home country. During 2010-2022, he served as Head of the Laboratory of Enzyme and Synthetic Biotechnology and the Institute of Chemical Biology of the National Hellenic Research Foundation (Greece). Since 2022, he is the Director of the Institute for Bio-innovation at the Biomedical Sciences Research Center “Alexander Fleming” (BSRC Fleming). Georgios Skretas has been awarded a Consolidator Grant by the European Research Council (ERC) (2019-2024) and a grant by the European Commission to establish an ERA Chair in Biomolecular Engineering and Synthetic Biology at BSRC Fleming (2023-2027). He is inventor in four (4) patents/patent applications. He is the Founder and Chief Executive Officer of ResQ Biotech, a spin-off company applying synthetic biology approaches to advance early-stage drug discovery against diseases caused by protein misfolding.